Healthcare practitioners should be aware of recent investigations and prosecutions for the purchase and distribution of non-FDA-approved narcotics from outside the U.S. Recent reports of U.S. Federal Drug Administration (“FDA”) activity puts a spotlight on not only the civil and criminal penalties at stake, but also the safety of patients. Concerned physicians and health care […]
Read more...